Clinical Trial

A Study in Healthy People to Test How Vicadrostat Affects the Heart

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The main objective of this trial is to investigate the effect of vicadrostat on the heart compared with placebo in healthy male and female volunteers.
Protocol Amendment History 3 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-08
critical Trial status changed: Active, Not Recruiting → Recruiting 2026-05-13
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-05-01
Trial Details
NCT Number NCT07513207
Lead Sponsor Boehringer Ingelheim
Conditions Healthy
Enrollment 45 participants
Start Date 2026-04-22
Primary Completion 2026-07-24 (estimated)
Study Completion 2026-08-21 (estimated)
Updated on ClinicalTrials.gov 2026-07-27